These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effect of oral contraceptives on the psyche and on sexuality].
    Author: Nahrendorf G, Carol W, Klinger G.
    Journal: Zentralbl Gynakol; 1978; 100(10):632-7. PubMed ID: 79278.
    Abstract:
    The problem of whether or not oral contraceptives affect the psychic function of the female is still controversal. The purpose of the present investigation was to study the occurrence of psychic and sexual effects in women taking either Ovosiston (mestranol 0,08 mg + chlormadinone acetate 2, 0 mg) or Non-Ovlon (ethinylestradiol 0,05 mg + norethisterone acetate 1,0 mg). 186 somatically healthy women were subject to two interviews, immediately before the start of therapy and six months after it. Most of the patients recorded distinctly alterations of their mood, their initiative, their elemental desires such as appetite, sleep, need of warmth, and their sexual behaviour. 73 of them noted a change in their emotional pattern, which was positive in 34 and negative in 39 cases. 99 women reported changes in their elemental desires. 136 patients exhibited alterations of their sexual behaviour, which were assessed as an improvement or impairment in 108 and 28 cases, respectively. There is a statistically significant correlation between the impairment of sexual function and the incidence of other untoward side effects. On the other hand, negative suggestion by poor experience of other women on by the influence of mass media seems to play a minor role in producing changes of sexual behaviour. There is, however, a clearcut relationship between negative suggestion and the incidence of unfavourable emotional alterations. The findings are discussed with reference to their clinical significance. Psychological and sexual effects of Ovosiston (0.08 mg mestranol and 2 mg chlormadinone acetate) and Non-Ovlon (0.05 mg ethinyl estradiol and 1.0 mg norethisterone acetate) were studied in 186 healthy women. Patients were interviewed immediately before beginning hormonal contraception, and after 6 months of treatment. Most (99) patients reported changes in mood, initiative, and elemental needs, including appetite, sleep, need for warmth, and sexual behavior. Changes in emotional pattern were reported by 73 patients. Alterations of sexual behavior were reported by 136 patients, and were considered improvements by 108. A statistically significant correlation between impairment of sexual function and the incidence of other undesirable side effects was noted. Negative suggestion from the experiences of other women and from the media seem to play a minor role in changes of sexual behavior. There is a clear relationship, however, between negative suggestion and the incidence of negative emotional changes. Clinical significance of these findings is discussed.
    [Abstract] [Full Text] [Related] [New Search]